Stauffer syndrome, clinical implications and knowledge gaps, does size matter? case report

dc.creatorChavarriaga Soto, Julián Andrés
dc.creatorFakih Garcia, Nayib Omar
dc.creatorCataño Cataño, Juan Guillermo
dc.creatorVillaquirán Torres, Claudio
dc.creatorRodriguez, Santiago
dc.creatorPatiño Sandoval, German Adolfo
dc.date2022-05-31T17:11:29Z
dc.date2023-05-11T17:15:34Z
dc.date2022-05-31T17:11:29Z
dc.date2023-05-11T17:15:34Z
dc.date2020
dc.date.accessioned2023-08-24T11:43:26Z
dc.date.available2023-08-24T11:43:26Z
dc.identifierhttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-020-00671-w
dc.identifier1471-2490
dc.identifierhttps://hdl.handle.net/20.500.12032/105982
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8420319
dc.descriptionBackgroundStauffer Syndrome (SS) is a paraneoplastic disorder associated with renal cell carcinoma (RCC). First described by Herbert Maurice Stauffer in 1961, it is characterized by hepatic dysfunction in the absence of metastasis, and elevated alkaline p
dc.formatPDF
dc.formatapplication/pdf
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCarcinomas
dc.subjectRenal Cell
dc.subjectParaneoplastic Syndrome
dc.subjectLiver Dysfunctions
dc.subjectJaundice
dc.subjectCholestatic
dc.subjectCase Report
dc.titleStauffer syndrome, clinical implications and knowledge gaps, does size matter? case report


Este ítem pertenece a la siguiente institución